MiNK Therapeutics, Inc.
INKT • NASDAQ
MiNK Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jennifer S. Buell, with a market cap of $51.7M.
CEOJennifer S. Buell
Next Earnings
Upcoming earnings announcement for MiNK Therapeutics, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.78
Earnings History
Past 11 earnings reports for MiNK Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.65Est: -$0.86 | +24.4% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$1.06Est: -$0.55 | -92.7% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.70Est: -$0.61 | -14.8% | — | — | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$0.62Est: -$0.50 | -24.0% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.05Est: -$0.08 | +37.5% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.07Est: -$0.10 | +30.0% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.11Est: -$0.15 | +26.7% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.16Est: -$0.15 | -6.7% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.15Est: -$0.18 | +16.7% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.18Est: -$0.20 | +10.0% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.17Est: -$0.24 | +29.2% | - | — | 10-Q |